Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/22/2010 | CA2740400A1 Ethanol production in microorganisms |
04/22/2010 | CA2740316A1 Conjugates of glp-1 agonists and uses thereof |
04/22/2010 | CA2740205A1 Methods for haplotype determination by haplodissection |
04/22/2010 | CA2740197A1 Modified variant bowman birk protease inhibitors |
04/22/2010 | CA2739675A1 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
04/22/2010 | CA2739046A1 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
04/22/2010 | CA2738472A1 Gene therapy vectors and cytosine deaminases |
04/22/2010 | CA2737595A1 Utilization of fatty acid desaturases from hemiselmis spp. |
04/22/2010 | CA2735974A1 Genetic loci associated with northern leaf blight resistance in maize |
04/21/2010 | EP2177628A2 Markers for diagnosis of cancer and its use |
04/21/2010 | EP2177626A1 Screening methods for cognitive enhancers |
04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
04/21/2010 | EP2177619A1 HSV strains for the oncolytic treatment of cancer |
04/21/2010 | EP2177618A2 Plants having improved growth characteristics and methods for making the same |
04/21/2010 | EP2177617A1 Rice promoters |
04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
04/21/2010 | EP2177615A1 Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases |
04/21/2010 | EP2177614A2 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer |
04/21/2010 | EP2177613A1 Recombinant vector capable of increasing secretion of Koji mold protease |
04/21/2010 | EP2177612A1 Method for obtaining information on formation of double-stranded nucleic acid |
04/21/2010 | EP2177611A1 Method for measurement of concentration of antigen |
04/21/2010 | EP2177610A1 Method for maintaining foreign gene in cell stably |
04/21/2010 | EP2177609A1 Marker gene for detection of tumor promoter, and method for detection of tumor promoter |
04/21/2010 | EP2177606A2 N-deoxyribosyltransferases from lactobacillus, corresponding nucleotide sequences and their applications |
04/21/2010 | EP2177605A1 Method for producing polyunsaturated fatty acids in transgenic non-human organisms |
04/21/2010 | EP2177604A1 Methods for identifying potential CYP4 metabolites, inhibitors or prodrugs |
04/21/2010 | EP2177535A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
04/21/2010 | EP2177531A2 Cell permeable peptide |
04/21/2010 | EP2177228A1 DNA vaccination for treatment of autoimmune disease |
04/21/2010 | EP2176433A2 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms |
04/21/2010 | EP2176417A1 Production of plants with decreased nitrite content |
04/21/2010 | EP2176416A2 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
04/21/2010 | EP2176414A1 Mammary gland-specific human erythropoietin expression vector, transgenic animal and method for producing human erythropoietin using same |
04/21/2010 | EP2176413A1 Immunology treatment for biofilms |
04/21/2010 | EP2176412A2 Bacterial mediated tnf- gene silencing |
04/21/2010 | EP2176411A2 Nanoparticle-mediated treatment for inflammatory diseases |
04/21/2010 | EP2176409A1 Nucleic acid construct systems capable of diagnosing or treating a cell state |
04/21/2010 | EP2176408A2 NUCLEIC ACIDS COMPRISING FORMULA (NuGiXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS |
04/21/2010 | EP2176407A2 Method of patterning a substrate |
04/21/2010 | EP2176406A1 Compositions and methods of treating cancer |
04/21/2010 | EP2176403A2 [nife]-hydrogenases having an improved resistance to dioxygen, process for obtaining them and their applications |
04/21/2010 | EP2176296A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
04/21/2010 | EP2176295A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
04/21/2010 | EP2176291A1 Expression of full length igg and secretion into the culture medium of prokaryotic cells |
04/21/2010 | EP2176288A2 Tnf superfamily collectin fusion proteins |
04/21/2010 | EP2176285A1 Plants having enhanced yield-related traits and a method for making the same |
04/21/2010 | EP2176283A2 Methods and compositions for treating brain diseases |
04/21/2010 | EP2176281A1 Nucleic acid sequences and combination thereof for sensitive amplification and detection of bacterial and fungal sepsis pathogens |
04/21/2010 | EP2175932A1 New neuronal viability factor and use thereof |
04/21/2010 | EP2175876A1 Agents containing proteases from stenotrophomonas maltophilia |
04/21/2010 | EP2175714A2 Transgenic plants with enhanced agronomic traits |
04/21/2010 | EP1819822B1 Plants having improved growth characteristics and method for making the same |
04/21/2010 | EP1819728B1 Il-7 variants with reduced immunogenicity |
04/21/2010 | EP1774032B1 Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same |
04/21/2010 | EP1716232B1 Acid alpha-glucosidase and fragments thereof |
04/21/2010 | EP1709167B1 Amylase |
04/21/2010 | EP1667732B1 Biodegradable polyacetals for in vivo polynucleotide delivery |
04/21/2010 | EP1660662B1 Regulatable gene expression in mammalian cells and mammals |
04/21/2010 | EP1654355B1 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |
04/21/2010 | EP1594960B1 Human cyclooxygenase-3 and uses thereof |
04/21/2010 | EP1585756B1 Delivery of sirnas |
04/21/2010 | EP1478742B1 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity |
04/21/2010 | EP1361274B1 Polypeptide having alpha-isomaltosylglucosaccharide synthase activity |
04/21/2010 | EP1354204B2 Hcv antigen/antibody combination assay |
04/21/2010 | EP1332217B1 Novel bacterial phytases and method for producing same |
04/21/2010 | EP1330526B1 Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family |
04/21/2010 | EP1311930B1 System and method for authenticating a user to a web server |
04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
04/21/2010 | EP1141361B1 Compositions and methods for packaging of alphavirus vectors |
04/21/2010 | EP1072010B1 Oligonucleotide mediated nucleic acid recombination |
04/21/2010 | EP0983372B1 Improved transaminase biotransformation process |
04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
04/21/2010 | CN1948480B Agricultural bacillus introduced eucommia trangenic method |
04/21/2010 | CN1891836B Method for quantitative measurement of gene expression based on paraffin-embedded tissue specimens |
04/21/2010 | CN1814761B Pyrroloquinoline quinone synthesis related gene and its coding protein |
04/21/2010 | CN101696454A RT-LAMP primer for visually detecting wild strains of classical swine fever virus |
04/21/2010 | CN101696448A Method for qualification of first specific mRNA with specific sequence |
04/21/2010 | CN101696442A Method for synthesizing cDNA in solution based on poly(A) RNA |
04/21/2010 | CN101696422A Method for transferring gene by injecting plant ovaries |
04/21/2010 | CN101696421A Recombination gene for strengthening endurance capacity of fishes to low dissolved oxygen stress and application thereof |
04/21/2010 | CN101696420A Method for improving resistance to wheat sharp eyespot |
04/21/2010 | CN101696419A Method for producing ethanol by using plant cellulose and hemicellulose |
04/21/2010 | CN101696418A Construction method of plasmid taking yeast G418 as selective marker |
04/21/2010 | CN101696417A Method for producing recombined cationic antibacterial peptide by adopting co-expression anionic ligand |
04/21/2010 | CN101696416A Novel cloning vector fusing rpsL gene with multiple cloning sites |
04/21/2010 | CN101696415A Oleic acid dehydrogenase gene and protein coded by same |
04/21/2010 | CN101696414A Gene capable of improving radiation resistance of organisms and application thereof |
04/21/2010 | CN101696413A SiRNA-935 capable of inhibiting BCLL11B expression and tumorous T cell proliferation and use thereof |
04/21/2010 | CN101696412A SiRNA-434 capable of inhibiting BCL11B expression and tumorous T cell proliferation and use thereof |
04/21/2010 | CN101696411A Method for quickly extracting fungal DNA for PCR amplification |
04/21/2010 | CN101696410A DNA extraction method suitable for structural analysis of microbial community in sediment |
04/21/2010 | CN101696409A Lysis buffer for high-throughput quantification of mrna, method for cell lysis and method for determination of accurate amount of leukocyte specific mrna |
04/21/2010 | CN101696408A Method for extracting DNA from single eggs of copepods |
04/21/2010 | CN101696403A Method for expressing isoamylase under control of pGAP of pichia pastoris |
04/21/2010 | CN101696399A Porcine reproductive and respiratory syndrome virus M protein CTL cell epitopes and application thereof |
04/21/2010 | CN101696397A Mesenchymal cells and osteoblasts from human embryonic stem cell |
04/21/2010 | CN101696272A Degradable material having multiple sensitive properties, manufacturing method thereof and use thereof |
04/21/2010 | CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |